Sabine Visser

496 total citations
30 papers, 310 citations indexed

About

Sabine Visser is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Sabine Visser has authored 30 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 12 papers in Radiation. Recurrent topics in Sabine Visser's work include Advanced Radiotherapy Techniques (12 papers), Radiation Therapy and Dosimetry (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Sabine Visser is often cited by papers focused on Advanced Radiotherapy Techniques (12 papers), Radiation Therapy and Dosimetry (10 papers) and Lung Cancer Treatments and Mutations (9 papers). Sabine Visser collaborates with scholars based in Netherlands, Germany and Switzerland. Sabine Visser's co-authors include Joachim G.J.V. Aerts, Bruno H. Stricker, Brenda L. Den Oudsten, Antje Knopf, Robin Cornelissen, Johannes A. Langendijk, Cássia O. Ribeiro, Stefan Both, Paul Lodder and Huub Belderbos and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, European Respiratory Journal and Thorax.

In The Last Decade

Sabine Visser

28 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sabine Visser Netherlands 10 173 110 103 79 26 30 310
Edward Yu Canada 13 249 1.4× 143 1.3× 66 0.6× 71 0.9× 24 0.9× 27 434
William Bodner United States 14 228 1.3× 167 1.5× 79 0.8× 103 1.3× 13 0.5× 42 393
Sean Brown United Kingdom 9 115 0.7× 80 0.7× 50 0.5× 101 1.3× 35 1.3× 20 306
K. Thomas United States 12 123 0.7× 53 0.5× 81 0.8× 114 1.4× 36 1.4× 29 378
Judi van Diessen Netherlands 7 287 1.7× 123 1.1× 73 0.7× 201 2.5× 16 0.6× 14 460
Melissa A.L. Vyfhuis United States 10 201 1.2× 182 1.7× 89 0.9× 60 0.8× 23 0.9× 30 390
Aydın Yavuz Türkiye 10 130 0.8× 81 0.7× 44 0.4× 77 1.0× 13 0.5× 33 326
David Skarsgard Canada 13 205 1.2× 112 1.0× 93 0.9× 68 0.9× 23 0.9× 25 450
Miriam M. Boxer Australia 10 122 0.7× 103 0.9× 104 1.0× 155 2.0× 52 2.0× 20 342
Rozita Abdul Malik Malaysia 10 87 0.5× 86 0.8× 129 1.3× 86 1.1× 43 1.7× 26 309

Countries citing papers authored by Sabine Visser

Since Specialization
Citations

This map shows the geographic impact of Sabine Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Visser more than expected).

Fields of papers citing papers by Sabine Visser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Visser. The network helps show where Sabine Visser may publish in the future.

Co-authorship network of co-authors of Sabine Visser

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Visser. A scholar is included among the top collaborators of Sabine Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Visser. Sabine Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Visser, Sabine, Erik W. Korevaar, Christina T. Muijs, et al.. (2023). Clinical 3D/4D cumulative proton dose assessment methods for thoracic tumours with large motion. Radiotherapy and Oncology. 182. 109575–109575. 6 indexed citations
2.
Visser, Sabine, Cássia O. Ribeiro, Véronique E. Mul, et al.. (2022). Robustness assessment of clinical adaptive proton and photon radiotherapy for oesophageal cancer in the model-based approach. Radiotherapy and Oncology. 177. 197–204. 9 indexed citations
3.
Nenoff, Lena, Michael Matter, Mirjana Josipović, et al.. (2021). Dosimetric influence of deformable image registration uncertainties on propagated structures for online daily adaptive proton therapy of lung cancer patients. Radiotherapy and Oncology. 159. 136–143. 26 indexed citations
4.
5.
Visser, Sabine, Stijn L.W. Koolen, Nico van Walree, et al.. (2021). Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer. Thorax. 76(11). 1150–1153. 6 indexed citations
6.
Visser, Sabine, Cássia O. Ribeiro, Erik W. Korevaar, et al.. (2021). Diaphragm-Based Position Verification to Improve Daily Target Dose Coverage in Proton and Photon Radiation Therapy Treatment of Distal Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics. 112(2). 463–474. 4 indexed citations
7.
Visser, Sabine, Hans Paul van der Laan, John Th. M. Plukker, et al.. (2020). A comprehensive motion analysis – consequences for high precision image-guided radiotherapy of esophageal cancer patients. Acta Oncologica. 60(3). 277–284. 7 indexed citations
8.
Laan, Hans Paul van der, Sabine Visser, Cássia O. Ribeiro, et al.. (2020). Weekly robustness evaluation of intensity-modulated proton therapy for oesophageal cancer. Radiotherapy and Oncology. 151. 66–72. 11 indexed citations
10.
Visser, Sabine, Stijn L.W. Koolen, Joachim G.J.V. Aerts, et al.. (2019). A limited sampling schedule to estimate individual pharmacokinetics of pemetrexed in patients with varying renal functions. Cancer Chemotherapy and Pharmacology. 85(1). 231–235. 7 indexed citations
11.
Visser, Sabine, Koen Bezemer, Joost P. Hegmans, et al.. (2019). Prediction of response to pemetrexed in non-small-cell lung cancer with immunohistochemical phenotyping based on gene expression profiles. BMC Cancer. 19(1). 440–440. 8 indexed citations
12.
Visser, Sabine, Stijn L.W. Koolen, Peter de Bruijn, et al.. (2019). Pemetrexed exposure predicts toxicity in advanced non–small-cell lung cancer: A prospective cohort study. European Journal of Cancer. 121. 64–73. 21 indexed citations
13.
Visser, Sabine, et al.. (2018). Renal impairment during pemetrexed maintenance in patients with advanced nonsmall cell lung cancer: a cohort study. European Respiratory Journal. 52(4). 1800884–1800884. 25 indexed citations
15.
Stoop, Marcel P., et al.. (2017). High and individually variable enzymatic activity precludes accurate determination of pemetrexed, methotrexate and their polyglutamate metabolite concentrations in plasma. Journal of Pharmaceutical and Biomedical Analysis. 148. 89–92. 3 indexed citations
17.
18.
Stoop, Marcel P., et al.. (2016). A new quantification method for assessing plasma concentrations of pemetrexed and its polyglutamate metabolites. Journal of Pharmaceutical and Biomedical Analysis. 128. 1–8. 5 indexed citations
19.
Visser, Sabine, et al.. (2015). Reliability and validity of the Cancer Therapy Satisfaction Questionnaire in lung cancer. Quality of Life Research. 25(1). 71–80. 12 indexed citations
20.
Visser, Sabine. (2008). Breast cancer : oncology. 12(5). 22–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026